Directed evolution of adeno-associated virus for efficient gene delivery to microglia
- PMID: 35879607
- DOI: 10.1038/s41592-022-01547-7
Directed evolution of adeno-associated virus for efficient gene delivery to microglia
Abstract
As the resident immune cells in the central nervous system (CNS), microglia orchestrate immune responses and dynamically sculpt neural circuits in the CNS. Microglial dysfunction and mutations of microglia-specific genes have been implicated in many diseases of the CNS. Developing effective and safe vehicles for transgene delivery into microglia will facilitate the studies of microglia biology and microglia-associated disease mechanisms. Here, we report the discovery of adeno-associated virus (AAV) variants that mediate efficient in vitro and in vivo microglial transduction via directed evolution of the AAV capsid protein. These AAV-cMG and AAV-MG variants are capable of delivering various genetic payloads into microglia with high efficiency, and enable sufficient transgene expression to support fluorescent labeling, Ca2+ and neurotransmitter imaging and genome editing in microglia in vivo. Furthermore, single-cell RNA sequencing shows that the AAV-MG variants mediate in vivo transgene delivery without inducing microglia immune activation. These AAV variants should facilitate the use of various genetically encoded sensors and effectors in the study of microglia-related biology.
© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.
Similar articles
-
High-Throughput In Vitro, Ex Vivo, and In Vivo Screen of Adeno-Associated Virus Vectors Based on Physical and Functional Transduction.Hum Gene Ther. 2020 May;31(9-10):575-589. doi: 10.1089/hum.2019.264. Epub 2020 Feb 26. Hum Gene Ther. 2020. PMID: 32000541 Free PMC article.
-
Gene transfer to the nigrostriatal system by hybrid herpes simplex virus/adeno-associated virus amplicon vectors.Hum Gene Ther. 1999 Oct 10;10(15):2481-94. doi: 10.1089/10430349950016825. Hum Gene Ther. 1999. PMID: 10543613
-
Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.J Gene Med. 2014 Sep-Oct;16(9-10):300-8. doi: 10.1002/jgm.2779. J Gene Med. 2014. PMID: 25303717
-
Novel Lung Tropic Adeno-Associated Virus Capsids for Therapeutic Gene Delivery.Hum Gene Ther. 2020 Sep;31(17-18):996-1009. doi: 10.1089/hum.2020.169. Epub 2020 Sep 8. Hum Gene Ther. 2020. PMID: 32799685 Review.
-
Adeno-associated virus-based vectors in gene therapy.J Biomed Sci. 2000 Jul-Aug;7(4):279-91. doi: 10.1007/BF02253246. J Biomed Sci. 2000. PMID: 10895050 Review.
Cited by
-
Expression-based selection identifies a microglia-tropic AAV capsid for direct and CSF routes of administration in mice.bioRxiv [Preprint]. 2024 Sep 27:2024.09.25.614546. doi: 10.1101/2024.09.25.614546. bioRxiv. 2024. PMID: 39386560 Free PMC article. Preprint.
-
A comprehensive review of AAV-mediated strategies targeting microglia for therapeutic intervention of neurodegenerative diseases.J Neuroinflammation. 2024 Sep 19;21(1):232. doi: 10.1186/s12974-024-03232-2. J Neuroinflammation. 2024. PMID: 39300451 Free PMC article. Review.
-
Simple and highly specific targeting of resident microglia with adeno-associated virus.iScience. 2024 Aug 12;27(9):110706. doi: 10.1016/j.isci.2024.110706. eCollection 2024 Sep 20. iScience. 2024. PMID: 39297168 Free PMC article.
-
Gene therapy for the leukodystrophies: From preclinical animal studies to clinical trials.Neurotherapeutics. 2024 Jul;21(4):e00443. doi: 10.1016/j.neurot.2024.e00443. Epub 2024 Sep 13. Neurotherapeutics. 2024. PMID: 39276676 Free PMC article. Review.
-
Adeno-associated virus-based gene therapy treats inflammatory kidney disease in mice.J Clin Invest. 2024 Aug 15;134(17):e174722. doi: 10.1172/JCI174722. J Clin Invest. 2024. PMID: 39225099 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous